FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

9004211000001109: Alvesco 160 inhaler (Covis Pharma Europe B.V.) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1670491000001118 Alvesco 160 inhaler (Covis Pharma Europe B.V.) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1670501000001110 Alvesco 160 inhaler (Covis Pharma Europe B.V.) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
20705301000001119 Alvesco 160 inhaler (Altana Pharma Limited) (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
20705401000001110 Alvesco 160 inhaler (Altana Pharma Limited) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39407901000001119 Alvesco 160 inhaler (Altana Pharma Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
47324201000001111 Alvesco 160 inhaler (Nycomed UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
73289101000001116 Alvesco 160 inhaler (Takeda UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
104611401000001113 Alvesco 160 inhaler (AstraZeneca UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Is a Ciclesonide 160micrograms/actuation inhaler CFC free true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has manufactured dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has active ingredient Ciclesonide false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has active ingredient Ciclesonide true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Is a Alvesco true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has specific active ingredient Ciclesonide true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has dispensed dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) Has manufactured dose form Pressurised inhalation false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 120 dose Is pack of False Alvesco 160 inhaler (Covis Pharma Europe B.V.) Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Is pack of False Alvesco 160 inhaler (Covis Pharma Europe B.V.) Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 60 dose Has AMP True Alvesco 160 inhaler (Covis Pharma Europe B.V.) Inferred relationship Existential restriction modifier
Alvesco 160 inhaler (Covis Pharma Europe B.V.) 120 dose Has AMP True Alvesco 160 inhaler (Covis Pharma Europe B.V.) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start